US FDA Clarifies: Coronavirus Vaccine Will Need Adcom Before Approval Decision
Executive Summary
In a JAMA article, senior FDA leaders state that the outside advisers will be needed to ensure transparency given the potentially widespread use of the vaccine.
You may also be interested in...
US FDA COVID-19 Adcom: What Additional Members Are Needed?
Beyond vaccine experts, specialists in medical areas where there might be safety concerns, as well as epidemiologists, could be helpful to aid the FDA in understanding the data in a coronavirus vaccine application.
COVID Vaccine Advisory Committee: Be Careful What You Wish For
The US FDA has promised to hold a public advisory committee review before authorizing or approving any COVID-19 vaccine candidates. What could possibly go wrong?
US FDA's Hahn Promotes Provider Role In Boosting Public Confidence In COVID-19 Products
Agency commissioner appeals to AMA audience to communicate message that FDA review decisions are based on good science.